BCA
TMO icon

Bray Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bray Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-39
Closed -$11K – 311
2019
Q3 		$11K Hold
39
– – ﹤0.01% 252
2019
Q2 		$11K Hold
39
– – ﹤0.01% 260
2019
Q1 		$11K Buy
+39
New +$9.71K ﹤0.01% 247
2015
Q4 		– Sell
-300
Closed -$37K – 289
2015
Q3 		$37K Hold
300
– – 0.02% 228
2015
Q2 		$39K Buy
+300
New +$39.1K 0.02% 235

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bray Capital Advisors's TMO Position: Q4 2019 in Review

Bray Capital Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2019, closing a stake of 39 shares — an estimated $11K sold.

Bray Capital Advisors first reported a position in TMO in Q2 2015 and held it in 5 quarters. The position peaked at $39K in Q2 2015. 1,678 funds tracked by Wall St. Rank hold TMO as of Q4 2019.

  • Bray Capital Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2019 after selling out during the quarter.
  • Bray Capital Advisors sold 39 Thermo Fisher Scientific shares in Q4 2019, an estimated $11K.
  • Bray Capital Advisors first reported a position in Thermo Fisher Scientific in Q2 2015 and held it in 5 quarters.
  • Bray Capital Advisors's Thermo Fisher Scientific position peaked at $39K in Q2 2015.
  • 1,678 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2019.

Based on Bray Capital Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.